Abeona Therapeutics Inc.
ABEO
$5.74
-$0.12-1.97%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 30.50% | 60.89% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 30.50% | 60.89% | |||
| Cost of Revenue | -24.92% | 28.30% | |||
| Gross Profit | 161.80% | 14.48% | |||
| SG&A Expenses | -18.80% | 3.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -21.16% | 12.08% | |||
| Operating Income | 40.72% | -0.53% | |||
| Income Before Tax | -18.26% | 17.42% | |||
| Income Tax Expenses | -- | 100.93% | |||
| Earnings from Continuing Operations | -18.25% | 16.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.25% | 16.54% | |||
| EBIT | 40.72% | -0.53% | |||
| EBITDA | 41.87% | -1.34% | |||
| EPS Basic | -17.34% | 18.60% | |||
| Normalized Basic EPS | -17.35% | 19.44% | |||
| EPS Diluted | -17.34% | 18.60% | |||
| Normalized Diluted EPS | -17.35% | 19.44% | |||
| Average Basic Shares Outstanding | 0.76% | 2.54% | |||
| Average Diluted Shares Outstanding | 0.76% | 2.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||